Pharmaceutico-analytical and clinical study of Gandhaka Druti and its Cream in the management of Vicharchika.

Pharmaceutico-Analytical and Clinical study of Gandhaka Druti and its Cream in the management of Vicharchika.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026496

Enrollment

Registered

2020-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: Group A Group B: Group A will be given Gandhak Druti Oil for local application. Group B will be given Gandhak Druti Cream for local application. Intervention2: Group A: Group A will b

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients having clinical signs and symptoms of Vicharchika. b)Patients between the age group of (16-70) years of age. c)Patients willing to participate in trial.

Exclusion criteria

Exclusion criteria: a)Patients suffering from chronic skin diseases. b)Patients under long term Steroids and cytotoxic treatments. c)Patients with concomitant illness like HTN, DM. d)Patients with evidence of malignancy.

Design outcomes

Primary

Measure	Time frame
Assessment of changes in specific signs and symptoms of Vicharchika (Eczema).Timepoint: 28 days	—

Secondary

Measure	Time frame
Any adverse effect in bodyTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Mohar Pal Meena

National Institute Of Ayurveda

moharpalmeena73@gmail.com9414564382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026